Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-EN
Language French English
Date Updated 2019-12-02 2019-11-29
Drug Identification Number 02347830 02347830
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name ROPIVACAINE HYDROCHLORIDE INJECTION USP ROPIVACAINE HYDROCHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 10 x 20mL GVL 10 x 20mL GVL
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-11-28
Actual start date 2019-11-28
Estimated end date 2020-01-31 2020-01-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments